About this trial

The goal of this study is to measure the prevalence and risks of hyperglycemia in surgical patients with prediabetes. The main questions it aims to answer are:

* What is the prevalence of hyperglycemia in surgical patients with prediabetes? * What is the relative risk of postoperative complications associated with hyperglycemia?

To answer these questions, surgical patients with prediabetes will undergo universal glucose measurement in the perioperative period. Glucose data will be analyzed in conjunction with electronic health record (EHR) data describing patient outcomes.

Eligibility criteria

Qualifiers

Hemoglobin A1c measurement between 6 and 6.4%

Scheduled for non-cardiac surgery

Disqualifiers

Age>18

Pregnancy

Any formal diabetes diagnosis

Current use of medications that influence blood glucose regardless of the indication

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

750 Participants
are grouped into 1 trial group

Locations

1
Foothills Medical Centre CalgaryAlberta, Canada

Sponsors and collaborators

University of Calgary

Lead sponsor